,"Author: Weber, Jonathan N.",,,,,,,,,,,
,,,,,,,,,,,,
,"h index = 34 (Of the 158 documents considered for the h-Index, 34 have been cited at least 34 times.)",,,,,,,,,,,
,Note: The h Index considers Scopus documents published after 1995.  ,,,,,,,,,,,
,,,,,,,,,,,,
,,,,,,,<2007,2007,2008,subtotal,>2008,total
Publication Year,Document Title,Authors,ISSN,Journal Title,Volume,Issue,4532,483,497,980,315,5827
2009,"Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: A cohort of high-risk men who have sex with men","Fox J., White P.J., Macdonald N., Weber J., McClure M., Fidler S., Ward H.",14642662,"HIV Medicine",10, 7,0,0,0,0,0,0
2009,"Adaptation of HIV-1 to human leukocyte antigen class I","Kawashima Y., Koizumi H., Kuse N., Oka S., Duda A., Prendergast A., Crawford H., Leslie A., Brumme Z., Brumme C., Allen T., Pfafferott K., Brander C., Kaslow R., Tang J., Hunter E., Allen S., Mulenga J., Branch S., Roach T., John M., Mallal S., Frater J., Ogwu A., Shapiro R., Prado J.G., Fidler S., Weber J., Pybus O.G., Klenerman P., Ndungu T., Phillips R., Heckerman D., Matthews P., Harrigan P.R., Walker B.D., Takiguchi M., Goulder P., Payne R., Addo M., Gatanaga H., Fujiwara M., Hachiya A.",00280836,"Nature",458, 7238,0,0,0,0,8,8
2009,"Re: ""Enhancement of HIV infection by cellulose sulfate,"" by Tao et al","McCormack S., Nunn A., Weber J., Taylor D., Richardson B., Darbyshire J., Sattentau Q., Karim Q.A., Abdool Karim S.S., Kharsany A., Lacey C.",08892229,"AIDS Research and Human Retroviruses",25, 3,0,0,0,0,0,0
2008,"Vaccinia virus strain NYVAC induces substantially lower and qualitatively different human antibody responses compared with strains Lister and Dryvax","Midgley C.M., Putz M.M., Weber J.N., Smith G.L.",00221317,"Journal of General Virology",89, 12,0,0,0,0,1,1
2008,"EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium","Bart P.-A., Wagner R., Liljestrom P., Kraehenbuhl J.-P., Girard M., Goudsmit J., Esteban M., Heeney J., Sattentau Q., McCormack S., Babiker A., Goodall R., Pantaleo G., Weber J., Barber T., Harari A., Guimaraes-Walker A., Khonkarly M., Sheppard N.C., Bangala Y., Frachette M.-J.",0264410X,"Vaccine",26, 25,0,0,1,1,2,3
2008,"EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone","McCormack S., Gamboni R., Burnet S., Legg K., Brodnicki E., Wolf H., Wagner R., Heeney J., Frachette M.-J., Tartaglia J., Babiker A., Stohr W., Pantaleo G., Weber J., Barber T., Bart P.-A., Harari A., Moog C., Ciuffreda D., Cellerai C., Cowen M.",0264410X,"Vaccine",26, 25,0,0,2,2,4,6
2008,"Participation in two phase II prophylactic HIV vaccine trials in the UK","Gray K., Legg K., Sharp A., Mackie N., Olarinde F., De Souza C., Weber J., Peters B.",0264410X,"Vaccine",26, 23,0,0,0,0,0,0
2008,"Human immunodeficiency virus (HIV)-specific T helper responses fail to predict CD4+ T cell decline following short-course treatment at primary HIV-1 infection","Fox J., Scriba T.J., Robinson N., Weber J.N., Phillips R.E., Fidler S.",00099104,"Clinical and Experimental Immunology",152, 3,0,0,0,0,0,0
2008,"Increasing incidence of acute hepatitis C in individuals diagnosed with primary HIV in the United Kingdom","Fox J., Nastouli E., Thomson E., Muir D., McClure M., Weber J., Fidler S.",02699370,"AIDS",22, 5,0,0,1,1,3,4
2008,"Primary HIV infection: To treat or not to treat?","Fidler S., Fox J., Porter K., Weber J.",09517375,"Current Opinion in Infectious Diseases",21, 1,0,0,2,2,2,4
2008,"An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses","Harari A., Barber T., Moog C., Liljestrom P., Wagner R., Wolf H., Kraehenbuhl J.-P., Esteban M., Heeney J., Frachette M.-J., Tartaglia J., Bart P.-A., McCormack S., Babiker A., Weber J., Pantaleo G., Stohr W., Tapia G., Garcia M., Medjitna-Rais E., Burnet S., Cellerai C., Erlwein O.",00221007,"Journal of Experimental Medicine",205, 1,0,0,22,22,14,36
2007,"Synergistic inhibition of HIV-1 infection by combinations of soluble polyanions with other potential microbicides","Gantlett K.E., Weber J.N., Sattentau Q.J.",01663542,"Antiviral Research",75, 3,0,0,4,4,8,12
2007,"Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection","Lucas M., Zachoval R., Pape G.R., Schraut W., Santantonio T., Nitschko H., Obermeier M., Phillips R., Scriba T.J., Semmo N., Day C., Ulsenheimer A., Weber J.N., Fidler S., Thimme R., Haberstroh A., Baumert T.F., Klenerman P., Diepolder H.M., Pfafferot K., Heeg M.H.J., Gaudieri S., Gruner N., Rauch A., Gerlach J.T., Jung M.-C.",19326203,"PLoS ONE",2, 7,0,1,6,7,1,8
2007,"Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: Findings from an observational cohort","Fidler S., Darbyshire J., Del Amo J., Gill N., Lee C., Meyer L., Rezza G., Fox J., Touloumi G., Pantazis N., Porter K., Babiker A., Weber J., Beral V., Coutinho R.",02699370,"AIDS",21, 10,0,0,5,5,4,9
2007,"A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl l-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection","Youle M., Di Palma F., Landonio S., Muscia F., Scarpini E., De Riz M., Porazzi D., La Spina I., Ubiali E., Foresti C., Pastore G., Osio M., Maggi P., Colomba A., Fundaro S., Pizzigallo E., D'Alessandro M., Dini M., Cingolati M., Di Gregorio P., Bollo M., Patti F., Cassetti I., Panto G., Calvani M., Iannuccelli M., Levy I., Burke M., Werner B., Portegies P., Weber J., Sharma R., Wilkins E., Bologna R., Bonnington A., Johnson M., Sabin C., Zala C., Losso M., Lourtau L., Defanti C.A., Causarano I.R.",14642662,"HIV Medicine",8, 4,0,0,4,4,6,10
2007,"Relation between chemokine receptor use, disease stage, and HIV-1 subtypes A and D: Results from a rural Ugandan cohort","Kaleebu P., Whitworth J.A.G., Nankya I.L., Yirrell D.L., Shafer L.A., Kyosiimire-Lugemwa J., Lule D.B., Morgan D., Beddows S., Weber J.",15254135,"Journal of Acquired Immune Deficiency Syndromes",45, 1,0,3,7,10,6,16
2007,"Precise identification of a human immunodeficiency virus type 1 antigen processing mutant","Zimbwa P., Zhang H.-T., Phillips R.E., Milicic A., Frater J., Scriba T.J., Willis A., Goulder P.J.R., Pillay T., Gunthard H., Weber J.N.",0022538X,"Journal of Virology",81, 4,0,2,2,4,1,5
2006,"Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy","Fox J., Dustan S., McClure M., Weber J., Fidler S.",14642662,"HIV Medicine",7, 7,0,5,9,14,3,17
2006,"Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-l-associated myelopathy: A randomised trial","Taylor G.P., Usuku K., Osame M., Bangham C.R.M., Weber J.N., Goon P., Furukawa Y., Green H., Barfield A., Mosley A., Nose H., Babiker A., Rudge P.",17424690,"Retrovirology",3, ,0,3,7,10,5,15
2006,"Factors associated with the development of opportunistic infections in HIV-1-infected adults with high CD4+ cell counts: A EuroSIDA study","Podlekareva D., Phillips A., Lundgren J.D., Mocroft A., Dragsted U.B., Ledergerber B., Beniowski M., Lazzarin A., Weber J., Clumeck N., Vetter N.",00221899,"Journal of Infectious Diseases",194, 5,0,8,8,16,3,19
2006,"Primary HIV","Fox J., Weber J., Fidler S.",13684973,"Sexually Transmitted Infections",82, 4,0,0,0,0,1,1
2006,"Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts","Frater A.J., Dustan S., Clarke J.R., Holmes E.C., Zhang H.T., Pfafferott K., Goulder P.J., McClure M.O., Weber J., Phillips R.E., Fidler S., Edwards C.T.T., McCarthy N., Fox J., Brown H., Milicic A., Mackie N., Pillay T., Drijfhout J.W.",0022538X,"Journal of Virology",80, 14,0,5,2,7,2,9
2006,"Direct measurement of in-vivo vaginal microbicide levels of PRO 2000 achieved in a human safety study","Lacey C.J.N., Wright A., Weber J.N., Profy A.T.",02699370,"AIDS",20, 7,3,3,2,5,4,12
2006,"Discordances between interpretation algorithms for genotypic resistance to protease and reverse transcriptase inhibitors of human immunodeficiency virus are subtype dependent","Snoeck J., Clarke J., Pillay C., Sirivichayakul S., Ariyoshi K., Holguin A., Rudich H., Rodrigues R., Bouzas M.B., Brun-Vezinet F., Reid C., Kantor R., Cahn P., Brigido L.F., Grossman Z., Soriano V., Sugiura W., Phanuphak P., Morris L., Weber J., Pillay D., Tanuri A., Shafer R.W., Harrigan R.P., Camacho R., Schapiro J.M., Katzenstein D., Vandamme A.-M., Van Laethem K., Deforche K., Carvalho A.P., Wynhoven B., Soares M.A., Cane P.",00664804,"Antimicrobial Agents and Chemotherapy",50, 2,5,4,10,14,8,27
2006,"Resistance to HIV drugs in UK may be lower in some areas [9]","Fox J.M., Fidler S., Weber J.",09598146,"British Medical Journal",332, 7534,2,1,2,3,2,7
2006,"Comparative potency of three antiretroviral therapy regimes in primary HIV infection","Fidler S., Fraser C., Fox J., Tamm N., Griffin J.T., Weber J.",02699370,"AIDS",20, 2,1,2,2,4,2,7
2005,"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study.","Cane P., Pozniak A., Sabin C., Smit E., Weber J., Zuckerman M., Chrystie I., Dunn D., Evans B., Geretti A.M., Green H., Phillips A., Pillay D., Porter K.",14685833,"BMJ (Clinical research ed.)",331, 7529,6,13,12,25,6,37
2005,"Ultrasensitive detection and phenotyping of CD4+ T cells with optimized HLA class II tetramer staining","Scriba T.J., Phillips R.E., Purbhoo M., Day C.L., Robinson N., Fidler S., Fox J., Weber J.N., Klenerman P., Sewell A.K.",00221767,"Journal of Immunology",175, 10,4,7,9,16,6,26
2005,"Sexual transmission of single human immunodeficiency virus type 1 virions encoding highly polymorphic multisite cytotoxic T-lymphocyte escape variants","Milicic A., Fidler S.J., Zhang H.-T., Phillips R.E., Edwards C.T.T., Hue S., Fox J., Brown H., Pillay T., Drijfhout J.W., Weber J.N., Holmes E.C.",0022538X,"Journal of Virology",79, 22,3,3,6,9,1,13
2005,"The development of vaginal microbicides for the prevention of HIV transmission","Weber J., Desai K., Darbyshire J.",15491277,"PLoS Medicine",2, 5,7,3,4,7,2,16
2005,"Neutralization sensitivity of HIV-1 Env-pseudotyped virus clones is determined by co-operativity between mutations which modulate the CD4-binding site and those that affect gp120-gp41 stability","Beddows S., Zheng N.N., Herrera C., Michael E., Barnes K., Moore J.P., Daniels R.S., Weber J.N.",00426822,"Virology",337, 1,1,1,1,2,0,3
2005,"Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: Results of a global collaboration","Kantor R., Snoeck J., Pillay C., Rudich H., Rodrigues R., Holguin A., Ariyoshi K., Bouzas M.B., Cahn P., Sugiura W., Soriano V., Katzenstein D.A., Brigido L.F., Grossman Z., Morris L., Vandamme A.-M., Tanuri A., Phanuphak P., Weber J.N., Pillay D., Harrigan P.R., Camacho R., Efron B., Schapiro J.M., Shafer R.W., Carvalho A.P., Wynhoven B., Cane P., Clarke J., Sirivichayakul S., Soares M.A.",15491277,"PLoS Medicine",2, ,16,10,7,17,1,34
2005,"The development of vaginal microbicides for the prevention of HIV transmission.","Weber J., Desai K., Darbyshire J.",15491676,"PLoS medicine.",2, 5,2,0,4,4,1,7
2005,"Human immunodeficiency virus type 1 in illicit-drug solutions used intravenously retains infectivity","Bobkov A.F., Selimova L.M., Khanina T.A., Zverev S.Y., Pokrovsky V.V., Weber J.N., Bobkov E.N., Rylkov A.V.",00951137,"Journal of Clinical Microbiology",43, 4,1,1,0,1,0,2
2005,"Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration.","Kantor R., Snoeck J., Pillay C., Rudich H., Rodrigues R., Holguin A., Ariyoshi K., Bouzas M.B., Cahn P., Sugiura W., Soriano V., Katzenstein D.A., Brigido L.F., Grossman Z., Morris L., Vandamme A.M., Tanuri A., Phanuphak P., Weber J.N., Pillay D., Harrigan P.R., Camacho R., Efron B., Schapiro J.M., Shafer R.W., Carvalho A.P., Wynhoven B., Cane P., Clarke J., Sirivichayakul S., Soares M.A.",15491676,"PLoS medicine.",2, 4,14,13,16,29,16,59
2005,"Risk of AIDS and death at given HIV-RNA and CD4 cell counts, in relation to specific antiretroviral drugs in the regimen","Olsen C.H., Phillips A.N., Gatell J., Ledergerber B., Katlama C., Friis-Moller N., Weber J., Horban A., Staszewski S., Lundgren J.D.",02699370,"AIDS",19, 3,11,14,3,17,2,30
2005,"HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound","Scriba T.J., Day C.L., Lucas M., Phillips R.E., Zhang H.-T., Brown H.L., Oxenius A., Tamm N., Fidler S., Fox J., Weber J.N., Klenerman P.",00219738,"Journal of Clinical Investigation",115, 2,12,10,4,14,1,27
2005,"The seroepidemiology of human T-lymphotropic viruses: Types I and II in Europe: A prospective study of pregnant women","Taylor G.P., Chieco-Bianchi L., Soriano V., Coste J., Ades A.E., Weber J.N., Bodeus M., Courtois F., Pauli G., Del Mistro A., Machuca A., Padua E., Andersson S., Goubau P.",15254135,"Journal of Acquired Immune Deficiency Syndromes",38, 1,5,4,2,6,2,13
2004,"The genetic variability of the protease-encoding region in HIV-1 A isolates and in CRF03 AB recombinants as observed in the CIS territory","Sukhanova A.L., Bobkov A.F., Kazennova E.V., Rudinsky N.I., Mikhailovich V.M., Gryadunov D.A., Budilov A.V., Bulavkina M.A., Weber J.N., Pokrovsky V.V.",05074088,"Voprosy Virusologii",49, 6,0,0,0,0,0,0
2004,"Declining prevalence of STI in the London sex industry, 1985 to 2002","Ward H., Day S., Green A., Cooper K., Weber J.",13684973,"Sexually Transmitted Infections",80, 5,12,5,8,13,4,29
2004,"Diversity of human immunodeficiency virus type 1 subtype A and CRF03_AB protease in Eastern Europe: Selection of the V77I variant and its rapid spread in injecting drug user populations","Roudinskii N.I., Sukhanova A.L., Kazennova E.V., Weber J.N., Pokrovsky V.V., Mikhailovich V.M., Bobkov A.F.",0022538X,"Journal of Virology",78, 20,7,2,3,5,3,15
2004,"Temporal trends in the HIV-1 epidemic in Russia: Predominance of subtype A","Bobkov A.F., Weber J.N., Pokrovsky V.V., Kazennova E.V., Selimova L.M., Khanina T.A., Ryabov G.S., Bobkova M.R., Sukhanova A.L., Kravchenko A.V., Ladnaya N.N.",01466615,"Journal of Medical Virology",74, 2,9,6,3,9,1,19
2004,"Detection of HIV-1 antiretroviral resistance from patients with persistently low but detectable viraemia","Mackie N., Dustan S., McClure M.O., Weber J.N., Clarke J.R.",01660934,"Journal of Virological Methods",119, 2,3,2,2,4,1,8
2004,"Clinical implications of stopping nevirapine-based antiretroviral therapy: Relative pharmacokinetics and avoidance of drug resistance","Mackie N.E., Fidler S., Tamm N., Clarke J.R., Back D., Weber J.N., Taylor G.P.",14642662,"HIV Medicine",5, 3,14,10,1,11,4,29
2004,"Long-term persistence of HIV-1 vaccine-induced CD4+CD45RA -CD62L-CCR7- memory T-helper cells","Balla-Jhagjhoorsingh S.S., Koopman G., Mooij P., Koornstra W., McCormack S., Weber J., Pantaleo G., Heeney J.L.",02699370,"AIDS",18, 6,3,0,1,1,1,5
2004,"Different Resistance Mutations Can be Detected Simultaneously in the Blood and the Lung of HIV-1 Infected Individuals on Antiretroviral Therapy","White N.C., Israel-Biet D., Coker R.J., Mitchell D.M., Weber J.N., Clarke J.R.",01466615,"Journal of Medical Virology",72, 3,1,0,0,0,1,2
2004,"Human T Cell Lymphotropic Virus Type I (HTLV-I)-Specific CD4+ T Cells: Immunodominance Hierarchy and Preferential Infection with HTLV-I","Goon P.K.C., Weber J.N., Bangham C.R.M., Igakura T., Hanon E., Mosley A.J., Barfield A., Barnard A.L., Kaftantzi L., Tanaka Y., Taylor G.P.",00221767,"Journal of Immunology",172, 3,16,2,0,2,3,21
2003,"Validity and utility of screening tests for STIs","Ward H., Weber J.",13684973,"Sexually Transmitted Infections",79, 5,1,0,0,0,0,1
2003,"High circulating frequencies of tumor necrosis factor alpha- and interleukin-2-secreting human T-lymphotropic virus type 1 (HTLV-1)-specific CD4+ T cells in patients with HTLV-1-associated neurological disease","Goon P.K.C., Igakura T., Hanon E., Mosley A.J., Asquith B., Gould K.G., Taylor G.P., Weber J.N., Bangham C.R.M.",0022538X,"Journal of Virology",77, 17,11,2,0,2,1,14
2003,"Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans","Pinon J.D., Klasse P.J., Jassal S.R., Welson S., Weber J., Brighty D.W., Sattentau Q.J.",0022538X,"Journal of Virology",77, 18,12,8,7,15,4,31
2003,"Oral pemphigus vulgaris associated with HIV infection","Hodgson T.A., Fidler S.J., Speight P.M., Weber J.N., Porter S.R.",01909622,"Journal of the American Academy of Dermatology",49, 2,2,2,2,4,0,6
2003,"Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers","Saito M., Weber J.N., Osame M., Bangham C.R.M., Braud V.M., Goon P., Hanon E., Taylor G.P., Saito A., Eiraku N., Tanaka Y., Usuku K.",00064971,"Blood",102, 2,7,1,0,1,0,8
2003,"Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes","Beddows S., McClure M., Weber J.N., Galpin S., Kazmi S.H., Ashraf A., Johargy A., Frater A.J., White N., Braganza R., Clarke J.",01466615,"Journal of Medical Virology",70, 3,19,2,0,2,1,22
2003,"Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity","Price D.A., Phillips R.E., Scullard G., Oxenius A., Braganza R., Beddows S.A., Kazmi S., Clarke J.R., Johnson G.E., Weber J.N.",0022538X,"Journal of Virology",77, 10,16,6,1,7,1,24
2003,"Changes in viral load in people with virological failure who remain on the same HAART regimen","Cozzi-Lepri A., Clotet B., Lundgren J.D., Phillips A.N., Miller V., Katlama C., Ledergerber B., Vella S., Weber J., Bruun J.N., Kirk O.",13596535,"Antiviral Therapy",8, 2,12,3,0,3,0,15
2003,"Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton","Igakura T., Stinchcombe J.C., Goon P.K.C., Taylor G.P., Weber J.N., Griffiths G.M., Tanaka Y., Osame M., Bangham C.R.M.",00368075,"Science",299, 5613,106,33,36,69,19,194
2003,"Comparison of metabolic abnormalities and clinical lipodystrophy 48 weeks after switching from HAART to Trizivir? versus continued HAART: The trizal study","Lafeuillade A., Demonty J., Bazin C., Bentata M., Bouvet E., Delfraissy J.F., Dellamonica P., Saint Marc T., De Saint Martin L., De Truchis P., Dien G., Clumeck N., Gallais H., Gil H., Hoen B., Katlama C., Lacoste D., Lang J.M., Beumont M., Massip P., Rozenbaum W., Mallolas J., Sereni D., Yeni P., Fenske S., Rockstroh J., Salzberger B., Schuermann D., Staszewski S., Mulcahy F., Lazzarin A., Milazzo F., Jaeger H., Moroni M., Cargnel A., Santos C., Flamholc L., Koppel K., Easterbrook P., Fisher M., Gazzard B., Kinghorn G., Weber J., Livrozet J.-M., Wilkins E., do Sameira Ferreira M., Johnson M., Cheret A., Antoun Z.",15284336,"HIV Clinical Trials",4, 1,15,1,3,4,0,19
2002,"Mutagenically separated PCR assay for rapid detection of M41L and K70R zidovudine resistance mutations in CRF01_AE (subtype E) human immunodeficiency virus type 1","Myint L., Fujita K., McClure M., Weber J.N., Sugiura W., Ariysoshi K., Yan H., Frater A.J., Auwanit W., Pathipvanith P., Yamada K., Matsuda M., Chiba T.",00664804,"Antimicrobial Agents and Chemotherapy",46, 12,4,1,0,1,1,6
2002,"Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load","Oxenius A., Scullard G., Weber J.N., McLean A.R., Phillips R.E., Price D.A., Dawson S.J., Gunthard H.F., Fischer M., Perrin L., Ramirez E., Fagard C.",02699370,"AIDS",16, 17,9,4,0,4,0,13
2002,"Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection","Fidler S., Weber J., Oxenius A., Brady M., Clarke J., Cropley I., Babiker A., Zhang H.-T., Price D., Phillips R.",02699370,"AIDS",16, 15,28,5,3,8,1,37
2002,"The HIV-infection outbreak in the town Lys'va (Perm region): homozygote genotype CCR5 delta32/CCR5 delta32 provides the high level of the persistence in the parenteral transmission of the virus | Vspyshka VICH-infektsii b g. Lys'va Permskoi oblasti: gomozigotnyi genotip CCR5 delta32/CCR5 delta32 obespechivaet vysokii uroven' ustoichivosti pri parenteral'noi peredache virusa.","Riabov G.S., Weber J.N., Kazennova E.V., Korepanova L.B., Mal'tseva E.A., Zhalnin V.V., Krasnikova L.A., Zverev S.I., Pokrovskii V.V., Bobkov A.F.",05074088,"Voprosy Virusologii",47, 4,0,0,0,0,0,0
2002,"Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy","Frater A.J., Dunn D.T., Beardall A.J., Ariyoshi K., Clarke J.R., McClure M.O., Weber J.N.",02699370,"AIDS",16, 8,44,16,8,24,4,72
2002,"Long-term follow-up: No effect of therapeutic vaccination with HIV-1 p17/p24:Ty virus-like particles on HIV-1 disease progression","Lindenburg C.E.A., Stolte I., Langendam M.W., Miedema F., Williams I.G., Colebunders R., Weber J.N., Fisher M., Coutinho R.A.",0264410X,"Vaccine",20, 17-18,17,1,6,7,0,24
2002,"High frequencies of Th1-type CD4+ T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis","Goon P.K.C., Hanon E., Igakura T., Tanaka Y., Weber J.N., Taylor G.P., Bangham C.R.M.",00064971,"Blood",99, 9,29,2,7,9,1,39
2002,"Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda","Kaleebu P., Weber J., Gilks C., Whitworth J., French N., Mahe C., Yirrell D., Watera C., Lyagoba F., Nakiyingi J., Rutebemberwa A., Morgan D.",00221899,"Journal of Infectious Diseases",185, 9,46,14,12,26,7,79
2002,"Association between secondary mutations in human immunodeficiency virus type 1 protease and therapeutic outcome (multiple letter)","Frater J., Dunn D., Weber J.N., McClure M.O., Perno C.-F., Cozzi-Lepri A., Balotta C., D'Arminio Monforte A.",00221899,"Journal of Infectious Diseases",185, 9,4,0,0,0,0,4
2002,"Observations of HIV-1 genotypic drug resistance in a trial of four reverse transcriptase inhibitors (Quattro Trial)","Kaye S., Back D., Blatchford N., Gazzard B., Gartland M., Jeffries D., Johnson M., Plummer K., Wills B., Kitchen V., Dunn D.T., Loveday C., Tedder R., Weller I.V.D., Withnall R., Babiker A.G., Darbyshire J.H., Hooker M.H., Nesarantnam S., Newberry A., Weber J., Breckenridge A.",13596535,"Antiviral Therapy",7, 1,2,0,0,0,0,2
2001,"Variable fate of virus-specific CD4+ T cells during primary HIV-1 infection","Oxenius A., Fidler S., Brady M., Dawson S.J., Ruth K., Easterbrook P.J., Weber J.N., Phillips R.E., Price D.A.",00142980,"European Journal of Immunology",31, 12,14,1,1,2,0,16
2001,"The pathogenesis of HIV-1 infection","Weber J.",00071420,"British Medical Bulletin",58, ,2,0,0,0,0,2
2001,"How important is the 'quality' of the cytotoxic T lymphocyte (CTL) response in protection against HIV infection?","Rowland-Jones S.L., Weber J., McMichael A., Appay V., Pinheiro S., Kaul R., Hansasuta P., Gillespie G., Dong T., Plummer F.A., Bwayo J.B., Fidler S.",01652478,"Immunology Letters",79, 1-2,33,5,4,9,2,44
2001,"Absence of viral transmission in injecting drug users in Russia [10]","Bobkov A.F., Samokhvalov E.I., Lvov D.K., Bobkova M.R., Pokrovsky V.V., Weber J.N.",01406736,"Lancet",358, 9286,3,0,1,1,1,5
2001,"HIV-1 drug resistance in primary infections in the UK [6]","Fidler S., Frater J., Clarke J., Weber J.",09598146,"British Medical Journal",323, 7313,8,0,1,1,0,9
2001,"Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients","Frater A.J., Beardall A., Ariyoshi K., Churchill D., Galpin S., Clarke J.R., Weber J.N., McClure M.O.",02699370,"AIDS",15, 12,64,6,5,11,1,76
2001,"'Chemical condoms' for the prevention of HIV infection: Evaluation of novel agents against SHIV89.6PD in vitro and in vivo","Weber J., Darbyshire J., Nunn A., O'Connor T., Jeffries D., Kitchen V., McCormack S., Stott J., Almond N., Stone A.",02699370,"AIDS",15, 12,47,3,4,7,3,57
2001,"High production of interferon ? but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells","Hanon E., Goon P., Taylor G.P., Hasegawa H., Tanaka Y., Weber J.N., Bangham C.R.M.",00064971,"Blood",98, 3,26,2,4,6,3,35
2001,"Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin","Oxenius A., Gunthard H.F., Fidler S., Weber J.N., Easterbrook P.J., Bell J.I., Phillips R.E., Price D.A.",00142980,"European Journal of Immunology",31, 4,127,17,17,34,12,173
2001,"Simple detection of point mutations associated with HIV-1 drug resistance","Frater A.J., Chaput C.C., Beddows S., Weber J.N., McClure M.O.",01660934,"Journal of Virological Methods",93, 1-2,5,1,1,2,1,8
2001,"An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methods of the initio trial","Babiker A.G., Conway B., Flepp M., Lelekis M., Girard P.-M., Hemmer R., Lundgren J., Mijch A., Mulcahy F., Ristola M., Darbyshire J.H., Salzberger B., Sandstrom E., Staszewski S., Weber J., De Wit S., Aboulker J.-P., Emery S., Floridia M., Gartland M., Manion D., Cooper D.A., Popescu M., Schnittman S., Stek M., Verbiest W., Flandre P., Law M., Schade-Brittinger C., Walker S., Bucciardini R., Boukli N., Hooker M.H., Carey D., Gargalianos P., Mollerup D., Brun-Vezinet F., Loveday C., Seligmann M., Withnall R., Yeni P., Angarano G., Antunes F., Churchill D.",01972456,"Controlled Clinical Trials",22, 2,9,1,0,1,0,10
2001,"Approaches to the development of broadly protective HIV vaccines: Challenges posed by the genetic, biological and antigenic variability of HIV-1","Barre-Sinoussi F., Makgoba W.M., Monico S.M., Nathanson N., Schild G., Wigzell H., Yamasaki S., Aubertin A.-M., Bartos M., Bermann P., Bradac J., Berkley S., Burke D., Cao H., Desrosiers R., Ensoli B., Fenyo E.M., Ferrari G., Galvao-Castro B., Godal T., Goudsmit J., Frachette M.-J., Bhamarapravati N., Ginsberg R., Heeney J., Holmes H., Jin X., Kalish M., Klein M., Korber B., Liu M., McMichael A., McCutchan F., Birx D., Mhalu F., Moscola J., Moss R., Mathieson B., Mbidde E., M'Boup S., Mullins J., Musonda R., Numberg J., Owili M., Bloom B., Peeters M., Pletschette M., Redfield R., Roudil M.-P., Salk P., Scarlatti G., Schultz A., Sheppard H., Stamatos L., Sutthent R., Carvalheiro J., Takebe Y., Tramont E., Van der Groen G., Virelizier J.-L., Voss G., Walker B., Weber J., Wyatt R., Young P., Zolla-Pazner S., Ganguly N., Seck A.C., Dias-Ferrao V., Esparza J., Melgaard B., Osmanov S., Pattou C., Piot P., Ntounga R.S., Toure C., Johnston M., Kazatchkine M.",02699370,"AIDS",15, 6,9,1,3,4,0,13
2001,"Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: Evidence of subtype homogeneity at the main sites of the epidemic","Bobkova M.R., Kazennova E.V., Selimova L.M., Buravtsova E.V., Lister S., Prilipov A.G., Weber J.N., Pokrovsky V.V., Bobkov A.F.",09564624,"International Journal of STD and AIDS",12, 1,4,0,1,1,0,5
2001,"An HIV type 1 subtype A strain of low genetic diversity continues to spread among injecting drug users in Russia: Study of the new local outbreaks in Moscow and Irkutsk","Bobkov A., Kazennova E., Khanina T., Bobkova M., Selimova L., Kravchenko A., Pokrovsky V., Weber J.",08892229,"AIDS Research and Human Retroviruses",17, 3,29,2,0,2,1,32
2001,"In vivo selection of T-cell receptor junctional region sequences by HLA-A2 human T-cell lymphotropic virus type 1 Tax11-19 peptide complexes","Saito M., Taylor G.P., Saito A., Furukawa Y., Usuku K., Weber J.N., Osame M., Bangham C.R.M.",0022538X,"Journal of Virology",75, 2,7,1,0,1,0,8
2000,"Fracticide among CD8+ T lymphocytes naturally infected with human T cell lymphotropic virus type I","Hanon E., Stinchcombe J.C., Saito M., Asquith B.E., Taylor G.P., Tanaka Y., Weber J.N., Griffiths G.M., Bangham C.R.M",10747613,"Immunity",13, 5,77,6,8,14,4,95
2000,"A prospective social and molecular investigation of gonococcal transmission","Ward H., Ison C.A., Day S.E., Martin I., Ghani A.C., Garnett G.P., Bell G., Kinghorn G., Weber J.N.",01406736,"Lancet",356, 9244,20,7,2,9,3,32
2000,"Comparative quantification of diverse serotypes of HIV-1 in plasma from a diverse population of patients","Clarke J.R., Galpin S., Braganza R., Ashraf A., Russell R., Churchill D.R., Weber J.N., McClure M.O.",01466615,"Journal of Medical Virology",62, 4,12,0,0,0,0,12
2000,"High frequency of viral protein expression in human T cell lymphotropic virus type 1-infected peripheral blood mononuclear cells","Hanon E., Asquith R.E., Taylor G.P., Tanaka Y., Weber J.N., Bangham C.R.M.",08892229,"AIDS Research and Human Retroviruses",16, 16,10,2,1,3,1,14
2000,"Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues","Clarke J.R., Kaye S., Babiker A.G., Hooker M.H., Tedder R., Weber J.N.",01660934,"Journal of Virological Methods",88, 2,8,0,0,0,0,8
2000,"HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations","Frater A.J., Chaput C.C., Weber J.N., McClure M.O.",02699370,"AIDS",14, 10,6,1,1,2,0,8
2000,"Serotype, parental country of birth, and ethnic status in unlinked anonymous neonatal HIV seroprevalence surveys [5]","Ades A.E., Parker S., Walker J., Weber J.N.",15254135,"Journal of Acquired Immune Deficiency Syndromes",24, 3,1,1,0,1,0,2
2000,"Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: Population study","Ades A.E., Parker S., Walker J., Edginton M., Taylor G.P., Weber J.N.",09598146,"British Medical Journal",320, 7248,17,2,1,3,3,23
2000,"Frequent reversible membrane damage in peripheral blood B cells in human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP)","Furukawa Y., Bangham C.R.M., Taylor G.P., Weber J.N., Osame M.",00099104,"Clinical and Experimental Immunology",120, 2,8,1,3,4,1,13
2000,"A phase I study of a novel potential intravaginal microbicide, PRO 2000, in healthy sexually inactive women","Van Damme L., Profy A., Laga M., Kitchen V., Wright A., Depraetere K., Rosenstein I., Vandersmissen V., Poulter L., McKinlay M., Van Dyck E., Weber J.",13684973,"Sexually Transmitted Infections",76, 2,52,7,7,14,5,71
2000,"An improved algorithm for determining HIV type 1 subtypes in a primary laboratory in Uganda","Kaleebu P., Whitworth J., Yirrell D., French N., Lyagoba F., Rutebemberwa A., Cheingsong-Popov R., Gilks C., Biryahwaho B., Weber J.",08892229,"AIDS Research and Human Retroviruses",16, 7,12,0,1,1,0,13
2000,"Mycoplasma species in rapid and slow HIV progressors","Ainsworth J.G., Hourshid S., Easterbrook P.J., Gilroy C.B., Weber J.N., Taylor-Robinson D.",09564624,"International Journal of STD and AIDS",11, 2,2,0,0,0,0,2
2000,"Abundant Tax protein expression in CD4+ T cells infected with human T- cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes","Hanon E., Bangham C.R.M., Hall S., Taylor G.P., Saito M., Davis R., Tanaka Y., Usuku K., Osame M., Weber J.N.",00064971,"Blood",95, 4,98,7,9,16,3,117
2000,"Silent mutation in the V3 region characteristic of HIV type 1 env subtype B strains from injecting drug users in the former Soviet Union","Bobkov A.F., Lukashov V.V., Goudsmit J., Weber J.N.",08892229,"AIDS Research and Human Retroviruses",16, 3,4,0,0,0,1,5
2000,"A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120(W61D) derived from dual tropic R5X4 HIV-1(ACH320)","McCormack S., Cheingsong R., Rees A., Babiker A., Banatvala J., Bruck C., Darbyshire J., Tyrrell D., Van Hoecke C., Weber J., Tilzey A., Carmichael A., Gotch F., Kepple J., Newberry A., Jones G., Lister S., Beddows S.",0264410X,"Vaccine",18, 13,31,3,4,7,2,40
2000,"HIV compartmentalization: Pathogenesis and clinical implications","Clarke J.R., White N.C., Weber J.N.",11396121,"AIDS Reviews",2, 1,1,0,1,1,0,2
1999,"A randomized, controlled, safety study using imiquimod for the topical treatment of anogenital warts in HIV-infected patients","Gilson R.J.C., Owens M.L., Shupack J.L., Friedman-Kien A.E., Conant M.A., Weber J.N., Nayagam A.T., Swann R.V., Pietig D.C., Smith M.H.",02699370,"AIDS",13, 17,46,9,4,13,1,60
1999,"Immunization with human immunodeficiency virus type 1 rgp120(W61D) in QS21/MPL adjuvant primes T cell proliferation and C-C chemokine production to multiple epitopes within variable and conserved domains of gp120(W61D)","Jones G.J., Von Hoegen P., Weber J., Rees A.D.",00221899,"Journal of Infectious Diseases",179, 3,14,1,3,4,0,18
1999,"Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy","Taylor G.P., Matutes E., Bangham C.R.M., Weber J.N., Hall S.E., Navarrete S., Michie C.A., Davis R., Witkover A.D., Rossor M., Nowak M.A., Rudge P.",0022538X,"Journal of Virology",73, 12,50,6,8,14,5,69
1999,"Risky business: Health and safety in the sex industry over a 9 year period","Ward H., Day S., Weber J.",13684973,"Sexually Transmitted Infections",75, 5,44,4,5,9,5,58
1999,"Rapid development of genotypic resistance to lamivudine when combined with zidovudine in pregnancy","Clarke J.R., Weber J.N., Taylor G.P., Braganza R., Mirza A., Stainsby C., Ait-Khaled M., Wright A., Lyall H., Parker D., McClure M.O.",01466615,"Journal of Medical Virology",59, 3,23,1,2,3,0,26
1999,"Prospective study of HTLV-I infection in an initially asymptomatic cohort","Taylor G.P., Bangham C.R.M., Weber J.N., Tosswill J.H.C., Matutes E., Daenke S., Hall S., Bain B.J., Davis R., Thomas D., Rossor M.",10779450,"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",22, 1,25,4,0,4,2,31
1999,"The rabbit study: Ritonavir and saquinavir in combination in saquinavir- experienced and previously untreated patients","Churchill D.R., Wills B., Sun E., Babiker A.G., Back D.J., Weber J.N., Pym A.S., Galpin S., Foxall R., Stainsby C., Clarke J.R., Kaye S., Bloor S., Larder B.A.",08892229,"AIDS Research and Human Retroviruses",15, 13,6,1,1,2,0,8
1999,"Role of maternal humoral immunity in vertical transmission of HIV-1 subtype E in Thailand","Louisirirotchanakul S., Beddows S., Cheingsong R., Shaffer N., Mastro T.D., Likanonsakul S., Wasi C., Taylor G.P., Weber J.N.",10779450,"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",21, 4,14,0,0,0,1,15
1999,"Sequence variations in human immunodeficiency virus type 1 Nef are associated with different stages of disease","Kirchhoff F., Easterbrook P.J., Douglas N., Troop M., Greenough T.C., Weber J., Carl S., Sullivan J.L., Daniels R.S.",0022538X,"Journal of Virology",73, 7,42,7,4,11,3,56
1999,"Immune correlates of protection from HIV and AIDS - More answers but yet more questions","Heeney J.L., Beverley P., McMichael A., Shearer G., Strominger J., Wahren B., Weber J., Gotch F.",01675699,"Immunology Today",20, 6,30,4,0,4,0,34
1999,"Measurement of plasma HIV viral load - Clinical applications","Churchill D., Weber J.",01634453,"Journal of Infection",38, 3,3,0,0,0,0,3
1999,"Intratype sequence variation among clinical isolates of the human papillomavirus type 6 L1 ORF: Clustering of mutations and identification of a frequent amino acid sequence variant","Caparros-Wanderley W., Savage N., Hill-Perkins M., Layton G., Weber J., Davies D.H.",00221317,"Journal of General Virology",80, 4,2,2,1,3,1,6
1999,"The in vivo effects of combination antiretroviral drug therapy on peripheral blood CD34+ cell colony-forming units from HIV type 1-infected patients","Adams G.B., Pym A.S., Poznansky M.C., McClure M.O., Weber J.N.",08892229,"AIDS Research and Human Retroviruses",15, 6,8,2,0,2,0,10
1999,"HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy","Jeffery K.J.M., Weber J.N., Lloyd A.L., Nowak M.A., Nagai M., Kodama D., Izumo S., Osame M., Bangham C.R.M., Usuku K., Hall S.E., Matsumoto W., Taylor G.P., Procter J., Bunce M., Ogg G.S., Welsh K.I.",00278424,"Proceedings of the National Academy of Sciences of the United States of America",96, 7,156,10,18,28,8,192
1999,"Comparison of the antibody repertoire generated in healthy volunteers following immunization with a monomeric recombinant gp120 construct derived from a CCR5/CXCR4-using human immunodeficiency virus type 1 isolate with sera from naturally infected individuals","Beddows S., Lister S., Cheingsong R., Bruck C., Weber J.",0022538X,"Journal of Virology",73, 2,31,9,3,12,0,43
1999,"Antiretroviral drug guidelines for the treatment of HIV infection. Should protease inhibitors always be included in the initial regimen or not?","Churchill D., Weber J.",11738804,"BioDrugs",11, 3,2,0,0,0,0,2
1998,"Mannose-binding protein in HIV-seropositive patients does not contribute to disease progression or bacterial infections","McBride M.O., Fischer P.B., Sumiya M., McClure M.O., Turner M.W., Skinner C.J., Weber J.N., Summerfield J.A.",09564624,"International Journal of STD and AIDS",9, 11,17,0,4,4,1,22
1998,"Characterization of sera from subjects infected with HIV-1 subtypes B and E in Thailand by antibody binding and neutralization","Louisirirotchanakul S., Beddows S., Cheingsong-Popov R., Shaffer N., Mastro T.D., Auewarakul P., Likanonsakul S., Wasi C., Weber J.",10779450,"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",19, 4,11,1,0,1,0,12
1998,"HIV type 1 gag D/env G recombinants in Russia","Bobkov A., Cheingsong-Popov R., Kazennova E., Selimova L., Ladnaya N., Kravchenko A., Foley B., Morrison I., Pokrovsky V., Weber J.",08892229,"AIDS Research and Human Retroviruses",14, 17,8,0,0,0,0,8
1998,"Hyperlipidaemia following treatment with protease inhibitors in patients with HIV-I infection [2]","Churchill D.R., Pym A.S., Babiker A.G., Back D.J., Weber J.N.",03065251,"British Journal of Clinical Pharmacology",46, 5,17,1,0,1,0,18
1998,"Quantification of proviral DNA load in human T-cell leukaemia virus type I infections","Tosswill J.H.C., Taylor G.P., Clewley J.P., Weber J.N.",01660934,"Journal of Virological Methods",75, 1,17,1,3,4,0,21
1998,"HIV and sexually transmitted disease","Weber J.",00071420,"British Medical Bulletin",54, 3,2,0,0,0,0,2
1998,"Usefulness of HIV-1 V3 serotyping in studying the HIV-1 epidemic in South Africa [1]","Cheingsong-Popov R., Martin D., Weber J., Williamson C., Lister S., Morris L., Van Harmelen J., Bredell H., Wood R., Sonnenberg P., Van der Ryst E.",02699370,"AIDS",12, 8,12,0,1,1,0,13
1998,"Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1","Rosenstein I.J., Stafford M.K., Kitchen V.S., Ward H., Weber J.N., Taylor-Robinson D.",00221899,"Journal of Infectious Diseases",177, 5,56,2,3,5,1,62
1998,"Intrapartum mucosal exposure to human immunodeficiency virus type 1 (HIV-1) of infants born to HIV-1-infected mothers correlates with maternal plasma virus burden","Ait-Khaled M., Hermione Lyall E.G., Stainsby C., Taylor G.P., Wright A., Weber J.N., McClure M.O., Tudor-Williams G.",00221899,"Journal of Infectious Diseases",177, 4,14,2,1,3,0,17
1998,"Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects","Stafford M.K., Ward H., Flanagan A., Rosenstein I.J., Taylor-Robinson D., Smith J.R., Weber J., Kitchen V.S.",10779450,"Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology",17, 4,131,7,12,19,3,153
1998,"Comparison of culture- and non-culture-based methods for quantification of viral load and resistance to antiretroviral drugs in patients given zidovudine monotherapy","Tedder R.S., Babiker A., Darbyshire J.H., Kaye S., Loveday C., Weller I.V.D., Jeffries D., Norman J., Weber J., Bourelly M., Foxall R.",00951137,"Journal of Clinical Microbiology",36, 4,5,1,0,1,0,6
1998,"Serotyping of HIV type 1 infections: Definition, relationship to viral genetic subtypes, and assay evaluation","Cheingsong-Popov R., Lister S., Weber J., Osmanov S., Pau C.-P., Schochetman G., Barin F., Holmes H., Francis G., Ruppach H., Dietrich U.",08892229,"AIDS Research and Human Retroviruses",14, 4,47,1,2,3,0,50
1998,"Review of uptake of interventions to reduce mother to child transmission of HIV by women aware of their HIV status","Hermione Lyall E.G., Walters S., Tudor-Williams G., Stainsby C., Taylor G.P., Ait-Khaled M., Bingham S., Evans J.A., Wright A., Weber J.N., McClure M.O.",09598146,"British Medical Journal",316, 7127,10,0,2,2,0,12
1998,"Neutralization of primary and T-cell line adapted isolates of human immunodeficiency virus type 1: Role of V3-specific antibodies","Beddows S., Louisirirotchanakul S., Cheingsong-Popov R., Easterbrook P.J., Simmonds P., Weber J.",00221317,"Journal of General Virology",79, 1,28,0,0,0,1,29
1997,"Subtyping and phylogenetic analysis of HIV-1 isolates from Russia","Bobkov A.F., Pokrovsky V.V., Selimova L.M., Kazennova Ye.V., Karaseva N.G., Ladnaya N.N., Kravchenko A.V., Cheingsong-Popov R., Weber J.",05074088,"Voprosy Virusologii",42, 1,3,0,0,0,0,3
1997,"Different subtypes of HIV-1 and cutaneous dendritic cells [3] (multiple letters)","Pope M., McLane M.F., Marlink R., Lee T.H., Ho D.D., Moore J.P., Weber J., Dittmar M.T., Weiss R.A., Essex M., Renjifo B., Pena-Cruz V.",00368075,"Science",278, 5339,15,1,0,1,1,17
1997,"HIV-1 viral load, phenotype, and resistance in a subset of drug-naive participants from the Delta trial","Brun-Vezinet F., Nunn A., Schuurman R., Seigneurin J.-M., Tamalet C., Tedder R., Weber J., Weverling G.-J., Boucher C., Loveday C., Descamps D., Fauveau V., Izopet J., Jeffries D., Kaye S., Krzyanowski C.",01406736,"Lancet",350, 9083,94,0,1,1,0,95
1997,"Trials and tribulations: Ethical dilemmas in HIV therapy","Weber J.",09527915,"Current Opinion in Immunology",9, 5,1,0,0,0,0,1
1997,"Langerhans cell tropism of human immunodeficiency virus type 1 subtype A through F isolates derived from different transmission groups","Dittmar M.T., Simmons G., Hibbitts S., O'Hare M., Louisirirotchanakul S., Beddows S., Weber J., Clapham P.R., Weiss R.A.",0022538X,"Journal of Virology",71, 10,68,6,1,7,2,77
1997,"Emergence of resistant variants of HIV in vivo during monotherapy with the proteinase inhibitor saquinavir","Ives K.J., Jacobsen H., Galpin S.A., Garaev M.M., Dorrell L., Mous J., Bragman K., Weber J.N.",03057453,"Journal of Antimicrobial Chemotherapy",39, 6,24,2,1,3,0,27
1997,"Sequence analysis of an HIV type 1 env subtype E isolate from Thailand with discordant V3-loop serotyping","Louisirirotchanakul S., Bobkov A., Shaffer N., Mastro T.D., Wasi C., Weber J., Cheingsong-Popov R.",08892229,"AIDS Research and Human Retroviruses",13, 9,4,0,0,0,0,4
1997,"HIV type 1 subtype E in Russia","Bobkov A., Cheingsong-Popov R., Selimova L., Ladnaya N., Kazennova E., Kravchenko A., Pokrovsky V., Weber J.",08892229,"AIDS Research and Human Retroviruses",13, 8,11,0,0,0,0,11
1997,"Association of antibodies to Chlamydia trachomatis heat-shock protein 60 kD with chronic nongonococcal urethritis","Horner P.J., Cain D., McClure M., Thomas B.J., Gilroy C., Ali M., Weber J.N., Taylor-Robinson D.",10584838,"Clinical Infectious Diseases",24, 4,20,1,1,2,2,24
1997,"CC-Chemokine receptor 5 genotypes and in vitro susceptibility to HIV-1 of a cohort of British HIV-exposed uninfected homosexual men [4]","Aarons E., Fernandez M., Rees A., McClure M., Weber J.",02699370,"AIDS",11, 5,10,0,0,0,0,10
1997,"CD4+ T-cell recognition of diverse clade B HIV-1 isolates","Fernandez M.H., Fidler S.J., Pitman R.J., Weber J.N., Rees A.D.M.",02699370,"AIDS",11, 3,9,0,0,0,0,9
1996,"HTLV-I associated uveitis: a report of two cases.","Sandy G.J., Taylor J., Steiger M., Wearne M., Weber J.N.",0950222X,"Eye (London, England)",10, ,1,0,0,0,0,1
1996,"The rising prevalence of HIV-1 infection in patients attending an inner city accident and emergency department","Poznansky M.C., Walters J., Cruikshank A., Pollock R., Dendrowskyj P., Lewis K., Parry J.V., Fothergill J., Weber J.",13510622,"Emergency Medicine Journal",13, 6,2,1,0,1,0,3
1996,"Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry","Simmons G., Weiss R.A., Clapham P.R., Wilkinson D., Reeves J.D., Dittmar M.T., Beddows S., Weber J., Carnegie G., Desselberger U., Gray P.W.",0022538X,"Journal of Virology",70, 12,283,6,5,11,4,298
1996,"Sexual partner networks in the transmission of sexually transmitted diseases: An analysis of gonorrhea cases in Sheffield, United Kingdom","Ghani A.C., Ison C.A., Ward H., Garnett G.P., Bell G., Kinghorn G.R., Weber J., Day S.",01485717,"Sexually Transmitted Diseases",23, 6,23,4,2,6,1,30
1996,"Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype","Weber J., Van De Perre P., Karita E., Wasi C., Sempala S., Tugume B., Biryahwaho B., Rubsamen-Waigmann H., Von Briesen H., Esser R., Grez M., Fenyo E.-M., Holmes H., Newberry A., Ranjhar S., Tomlinson P., Bradac J., Beddows S., Kaleebu P., Bjorndal A., Osmanov S., Heyward W., Esparza J., Galvao-Castro B.",0022538X,"Journal of Virology",70, 11,80,2,4,6,2,88
1996,"The UK register of HIV seroconverters: Methods and analytical issues","Beral V., Jeffries D., Johnson A.M., Johnson M.A., McMichael A.J., Mortimer P.P., Phillips A.N., Porter K., Pozniak A., Weber J., Wellsteed S., Babiker A., Breltle R.P., Carne C., Darbyshire J.H., Evans B.G., Gilson R.J.C., Goldberg D., Hawkins D.A.",09502688,"Epidemiology and Infection",117, 2,7,0,1,1,0,8
1996,"No evidence of antibody to human foamy virus in widespread human populations","Ali M., McClure M.O., Taylor G.P., Pitman R.J., Parker D., Rethwilm A., Cheingsong-Popov R., Weber J.N., Bieniasz P.D., Bradley J.",08892229,"AIDS Research and Human Retroviruses",12, 15,36,2,1,3,0,39
1996,"Immunization with recombinant p17/p24:Ty virus-like particles in human immunodeficiency virus-infected persons","Veenstra J., Uthayakumar S., Gow I.R., Weber J.N., Coutinho R.A., Williams I.G., Colebunders R., Dorrell L., Tchamouroff S.E., Patou G., Lange J.M.A., Weller I.V.D., Goeman J.",00221899,"Journal of Infectious Diseases",174, 4,22,0,0,0,0,22
1996,"Isolated cutaneous non-tuberculous mycobacterial infection as a manifestation of AIDS","Paige D.G., Price D.A., Crook T., Main J., Fry L., Weber J.N.",03076938,"Clinical and Experimental Dermatology",21, 3,0,0,0,0,0,0
1996,"Sequence analysis of the glycoprotein 120 coding region of a new human immunodeficiency virus type 1 subtype G strain from Russia","Bobkov A., Weber J., Cheingsong-Popov R., Karasyova N., Selimova L., Kravchenko A., Bochkova M., Kazennova E., Ladnaya N., Pokrovsky V.",08892229,"AIDS Research and Human Retroviruses",12, 14,9,0,0,0,0,9
1996,"An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones","Fidler S.J., Dorrell L., Ball S., Lombardi G., Weber J., Hawrylowicz C., Rees A.D.M.",00192805,"Immunology",89, 1,15,1,0,1,0,16
1996,"Antigen capture ELISA for the heat shock protein (hsp60) of Chlamydia trachomatis","Horner P.J., Ali M., Parker D., Weber J.N., Taylor-Robinson D., McClure M.O.",00219746,"Journal of Clinical Pathology",49, 8,4,0,0,0,0,4
1996,"High activated and memory cytotoxic T-cell responses to HTLV-1 in healthy carriers and patients with tropical spastic paraparesis","Daenke S., Kermode A.G., Hall S.E., Taylor G., Weber J., Nightingale S., Bangham C.R.M.",00426822,"Virology",217, 1,59,5,2,7,0,66
1996,"Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G","Gao F., Von Briesen H., Beddows S., Weber J., Sharp P.M., Shaw G.M., Hahn B.H., Osmanov S., Heyward W.L., Esparza J., Morrison S.G., Robertson D.L., Thornton C.L., Craig S., Karlsson G., Sodroski J., Morgado M., Galvao-Castro B.",0022538X,"Journal of Virology",70, 3,151,10,16,26,2,179
1996,"Glycoprotein 120 polymorphism in an HIV type 1 epidemic originating from a point source: Nucleotide sequence analysis of variants with conserved V3 loop sequences","Bobkov A., Cheingsong-Popov R., Garaev M., Weber J.",08892229,"AIDS Research and Human Retroviruses",12, 3,5,0,0,0,0,5
1996,"Complex mosaic structure of the partial envelope sequence from a gambian HIV type 1 isolate","Bobkov A., Cheingsong-Popov R., Salminen M., McCutchan F., Louwagie J., Ariyoshi K., Whittle H., Weber J.",08892229,"AIDS Research and Human Retroviruses",12, 2,11,0,0,0,0,11
1996,"HTLV-I screening in Britain [5]","Kay L.A., Breuer J., Weber J.N., Taylor G.P., Harrison P., Ala F.A., Milligan D.W., Skidmore S., Jenks P.J., Raftery M.J.",09598146,"British Medical Journal",312, 7032,3,0,0,0,0,3
1996,"HIV clearance in infants [15]","McClure M.O., Zevallos E.A., Gu J., Goulder P.J., Ogg G., McMichael A.J., Weber J.N., Newell M.-L., Dunn D., Anderson V.M., Bard E.",01406736,"Lancet",347, 9008,3,0,0,0,0,3
1996,"HTLV-1 associated uveitis: A report of two cases [1]","Sandy C.J., Taylor G., Steiger M., Wearne M., Weber J.N.",0950222X,"Eye",10, 4,1,0,0,0,0,1
1995,"Safety and activity of saquinavir in HIV infection","Kitchen V.S., Weber J.N., Skinner C., Ariyoshi K., Lane E.A., Duncan I.B., Burckhardt J., Burger H.U., Bragman K., Pinching A.J.",01406736,"Lancet",345, 8955,79,1,0,1,0,80
1995,"HIV positive patients first presenting with an AIDS defining illness: Characteristics and survival","Poznansky M.C., Coker R., Skinner C., Hill A., Bailey S., Whitaker L., Renton A., Weber J.",09598146,"British Medical Journal",311, 6998,42,2,0,2,1,45
1995,"Emerging proteinase inhibitors [13]","Kitchen V., Stewart F., Bragman K., Weber J.",01406736,"Lancet",345, 8963,1,0,0,0,0,1
1995,"Safety and activity of saquinavir in HIV infection","Kitchen V.S., Weber J.N., Lipsky J.J., Skinner C., Ariyoshi K., Lane E.A., Duncan I.B., Burckhardt J., Burger H.U., Bragman K., Pinching A.J.",01406736,"Lancet",345, 8955,61,4,2,6,0,67
1995,"Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate [19]","McBride M.O., Linney M., Davidson R.N., Weber J.N.",10584838,"Clinical Infectious Diseases",21, 3,10,1,1,2,1,13
1995,"The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition","Fernandez M.H., Faith A., Higgins J.A., Weber J., Rees A.D.M.",00192805,"Immunology",85, 2,6,0,0,0,0,6
1995,"HIV clearance in an infant? [4]","McClure M.O., Bryson Y., Chen I.S.Y., Bieniasz P.D., Weber J.N., Tedder R.S., O'Shea S., Banatvala J.E., Tudor-Williams G., Simmonds P., Holmes E.C.",00280836,"Nature",375, 6533,5,0,0,0,0,5
1995,"Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: A phase I/II study","Van Leeuwen R., McDade H., Danner S.A., Katlama C., Kitchen V., Boucher C.A.B., Tubiana R., McBride M., Ingrand D., Weber J., Hill A.",00221899,"Journal of Infectious Diseases",171, 5,92,0,0,0,1,93
1995,"Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies","D'Souza M.P., Laman J., Mascola J., Rasheed S., Richman D., Schuitemaker H., Thiriart C., Wainberg M., Weber J., Beddows S., Tilley S., Milman G., Bradac J.A., McPhee D., Hanson C.V., Hendry R.M., Corcoran T., Stott J., Fung M.",02699370,"AIDS",9, 8,40,1,1,2,1,43
1995,"Identification of HIV-1 subtype G from Uganda","Kaleebu P., Bobkov A., Cheingsong-Popov R., Bieniasz P., Garaev M., Weber J.",08892229,"AIDS Research and Human Retroviruses",11, 5,24,0,0,0,0,24
1995,"Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: Sustained reduction in viral markers","Ingrand D., Valentin M.A., Gentilini M., Van Leeuwen R., Danner S.A., Kitchen V., McBride M., Weber J., Boucher C.A.B., Loveday C., Robert C., Hill A., Cammack N., Katlama C., Tubiana R.",02699370,"AIDS",9, 12,22,2,1,3,4,29
1995,"Naturally occurring variants of human T-cell leukemia virus type I tax protein impair its recognition by cytotoxic T lymphocytes and the transactivation function of tax","Niewiesk S., Daenke S., Parker C.E., Taylor G., Weber J., Nightingale S., Bangham C.R.M.",0022538X,"Journal of Virology",69, 4,65,1,2,3,1,69
1994,"Identification of an env G subtype and heterogeneity of HIV-1 strains in the Russian Federation and Belarus","Bobkov A., Janssens W., Van Der Groen G., McCutchan F., Weber J., Cheingsong-Popov R., Garaev M., Rzhaninova A., Kaleebu P., Beddows S., Bachmann M.H., Mullins J.I., Louwagie J.",02699370,"AIDS",8, 12,52,3,1,4,1,57
1994,"The transactivator gene of human T-cell leukemia virus type I is more variable within and between healthy carriers than patients with tropical spastic paraparesis","Niewiesk S., Daenke S., Parker C.E., Taylor G., Weber J., Nightingale S., Bangham C.R.M.",0022538X,"Journal of Virology",68, 10,60,2,3,5,1,66
1994,"Adverse effects of drugs used in the management of opportunistic infections associated with HIV infection","Peters B.S., Carlin E., Weston R.J., Loveless S.J., Sweeney J., Weber J., Main J.",01145916,"Drug Safety",10, 6,10,1,1,2,0,12
1994,"Circulating anti-tax cytotoxic T lymphocytes from human T-cell leukemia virus type I-infected people, with and without tropical spastic paraparesis, recognize multiple epitopes simultaneously","Parker C.E., Nightingale S., Taylor G.P., Weber J., Bangham C.R.M.",0022538X,"Journal of Virology",68, 5,75,5,1,6,2,83
1994,"Molecular epidemiology of HIV-1 in the former Soviet Union: Analysis of env V3 sequences and their correlation with epidemiologic data","Bobkov A., Garaev M.M., Rzhaninova A., Kaleebu P., Pitman R., Weber J.N., Cheingsong-Popov R.",02699370,"AIDS",8, 5,39,0,0,0,1,40
1994,"Diarrhoea associated with Clostridium difficile in AIDS patients receiving rifabutin [6]","McBride M.O., Coker R.J., Horner P.J., Weston R., Weber J.N.",01406736,"Lancet",343, 8894,3,0,0,0,1,4
1994,"Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cells","Shaunak S., Gooderham N.J., Edwards R.J., Payvandi N., Javan C.M., Baggett N., MacDermot J., Weber J.N., Davies D.S.",00071188,"British Journal of Pharmacology",113, 1,27,2,1,3,2,32
1994,"Development of a rapid quantitative assay for HIV-1 plasma infectious viraemia-culture-PCR (CPID)","Ariyoshi K., Bloor S., Bieniasz P.D., Bourrelly M., Foxall R., Weber J.N.",01466615,"Journal of Medical Virology",43, 1,4,0,0,0,0,4
1994,"Undergraduate teaching in genitourinary medicine","Peters B.S., Weber J.N.",02664348,"Genitourinary Medicine",70, 5,2,0,0,0,0,2
1994,"HIV infection in inner city A and E department [10]","Barton S.E., Booth S.J., Poznansky M., Torkington J., Fothergill J., Touquet R., Weber J.",09598146,"British Medical Journal",308, 6944,0,0,0,0,0,0
1994,"Serotyping HIV type 1 by antibody binding to the V3 loop: Relationship to viral genotype","Cheingsong-Popov R., Esparza J., Galvao-Castro B., Van de Perre P., Karita E., Wasl C., Sempala S., Tugume B., Biryahwaho B., Rubsamen-Waigmann H., Von Briesen H., Lister S., Callow D., Kaleebu P., Beddows S., Weber J., Osmanov S., Belsey E.M., Heyward W.",08892229,"AIDS Research and Human Retroviruses",10, 11,68,1,2,3,0,71
1994,"Visceral leishmaniasis following treatment with liposomal amphotericin B [12]","McBride M., Linney M., Claydon E.J., Weber J.",10584838,"Clinical Infectious Diseases",19, 2,11,1,0,1,1,13
1993,"HIV replication in CD4-negative cell lines: Effect of cloning, CD4 expression and inhibitory by dextrin sulphate","Beddows S., Bieniasz P., Shaunak S., Weber J.",09563202,"Antiviral Chemistry and Chemotherapy",4, 3,5,0,0,0,0,5
1993,"Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1","Katseni V.L., Gilroy C.B., Ryait B.K., Ariyoshi K., Bieniasz P.D., Weber J.N., Taylor-Robinson D.",01406736,"Lancet",341, 8840,53,0,1,1,1,55
1993,"Genetic techniques and surveillance of tuberculosis [20]","Day S., Ison C., Ward H., Weber J.",01406736,"Lancet",342, 8886-8887,2,0,0,0,0,2
1993,"Antibody to specific HIV-1 proteins in oral mucosal transudates [6]","Cheingsong-Popov R., Callow D., Weber J., Holm-Hansen C., Constantine N.T.",01406736,"Lancet",341, 8861,4,0,0,0,0,4
1993,"Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV-1-infected individuals","Bieniasz P.D., Ariyoshi K., Bourelly M.A.D., Bloor S., Foxall R.B., Harwood E.C., Weber J.N.",02699370,"AIDS",7, 6,17,0,0,0,1,18
1993,"Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses","Martin S.J., Gotch F.M., McMichael A.J., Roitt I.M., Weber J.N., Vyakarnam A., Cheingsong-Popov R., Callow D., Jones K.L., Senior J.M., Adams S.E., Kingsman A.J., Matear P.",02699370,"AIDS",7, 10,34,1,1,2,1,37
1993,"Outpatient follow-up in women with HIV infection in Parkside Health Authority (UK)","Horner P.J., McBride M., Coker R.J., Crowley S., Harris J.R.W., Murphy S.M., Weber J.N., Renton A.M.",02664348,"Genitourinary Medicine",69, 5,5,0,0,0,0,5
1993,"Identification of human immunodeficiency virus type 1 subtypes and their distribution in the Commonwealth of Independent States (former Soviet Union) by serologic V3 peptide-binding assays and V3 sequence analysis","Cheingsong-Popov R., Weber J.N., Bobkov A., Garaev M.M., Kaleebu P., Callow D., Rzhiminova A., Saukhat S.R., Burdajev N.P., Kolomijets N.D.",00221899,"Journal of Infectious Diseases",168, 2,14,0,0,0,0,14
1993,"HIV quiet but not silent [8]","Weber J., McClure M.",00280836,"Nature",364, 6433,0,0,0,0,0,0
1992,"Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?","Ariyoshi K., Harwood E., Chiengsong-Popov R., Weber J.",01406736,"Lancet",340, 8830,32,0,0,0,0,32
1992,"Co-trimoxazole versus dapsone-pyrimethamine for prevention of Pneumocystis carinii pneumonia [12]","Coker R.J., Nieman R., McBride M., Mitchell D.M., Harris J.R.W., Weber J.N.",01406736,"Lancet",340, 8827,4,0,0,0,0,4
1992,"Clinical aspects of mycobacterial infections in HIV infection","Coker R.J., Hellyer T.J., Brown I.N., Weber J.N.",09232508,"Research in Microbiology",143, 4,6,0,0,0,1,7
1992,"A Phase I clinical study of the safety, toxicity, and immunogenicity of the Ty,p24,VLP in healthy volunteers - Interim report","Weber J., Adams S., Kingsman A., Kennedy A., Callow D., Zigmond A., Popov R.C., Martin S., Vyakarnam A., Gutch F., McMichael A.",08892229,"AIDS Research and Human Retroviruses",8, 8,0,0,0,0,0,0
1992,"Eight year prospective study of HIV infection in a cohort of homosexual men - Clinical progression, immunological and virological markers","Lau R.K.W., Pinching A.J., Hill A., Jenkins P., Caun K., Forster S.M., Weber J.N., McManus T.J., Harris J.R.W., Jeffries D.J.",09564624,"International Journal of STD and AIDS",3, 4,6,0,0,0,0,6
1992,"Application of screening and confirmatory assays for anti-HTLV-I/II in U.K. populations","Tosswill J.H.C., Parry J.V., Weber J.N.",01466615,"Journal of Medical Virology",36, 3,7,0,0,0,0,7
1992,"Development of HIV-1 group-specific neutralizing antibodies after seroconversion","McKnight A., Clapham P.R., Goudsmit J., Cheingsong-Popov R., Weber J.N., Weiss R.A.",02699370,"AIDS",6, 8,14,1,0,1,0,15
1992,"Investigations into the mechanism by which sulfated polysaccharides inhibit HIV infection in vitro","McClure M.O., Moore J.P., Blanc D.F., Scotting P., Cook G.M.W., Keynes R.J., Weber J.N., Davies D., Weiss R.A.",08892229,"AIDS Research and Human Retroviruses",8, 1,77,4,6,10,2,89
1992,"Contribution of maternal viral load to HIV-1 transmission [23]","Ariyoshi K., Weber J., Walters S.",01406736,"Lancet",340, 8816,0,0,0,0,0,0
1992,"Trends in sexual behaviour in a cohort of homosexual men: A 7 year prospective study","Lau R.K.W., Jenkins P., Caun K., Forster S.M., Weber J.N., McManus T.J., Harris J.R.W., Jeffries D.J., Pinching A.J.",09564624,"International Journal of STD and AIDS",3, 4,2,0,0,0,0,2
1992,"Geographic diversity of human immunodeficiency virus type 1: Serologic reactivity to env epitopes and relationship to neutralization","Cheingsong-Popov R., Watts D.M., Constantine N.T., Weber J.N., Callow D., Beddows S., Shaunak S., Wasi C., Kaleebu P., Gilks C., Petrascu I.V., Garaev M.M.",00221899,"Journal of Infectious Diseases",165, 2,17,0,0,0,0,17
1991,"Comparative humoral responses to HIV-1 p24(gag) and gp120(env) in subjects from East Africa and the UK","Kaleebu P., Were J.B.O., Weber J., Cheingsong-Popov R., Callow D., Katabira E., Mubiru F., Biryahwaho B., Sempala S., Gilks C., Brindle R.",02699370,"AIDS",5, 8,3,0,0,0,0,3
1991,"Autoimmune disease and HTLV-1 infection","Bowness P., Davies K.A.A., Tosswill J., Bunn C.C., MacAlpine L., Weber J.N., Walport M.J.",02637103,"British Journal of Rheumatology",30, 2,10,0,1,1,0,11
1991,"Dextrin sulphate and fucoidan are potent inhibitors of HIV infection in vitro","McClure M.O., Keynes R.J., Weiss R.A., Whitby D., Patience C., Gooderham N.J., Bradshaw A., Cheingsong-Popov R., Weber J.N., Davies D.S., Cook G.M.W.",09563202,"Antiviral Chemistry and Chemotherapy",2, 3,17,2,0,2,0,19
1991,"Isolation of measles virus from child with Kawasaki disease [24]","Whitby D., Hoad J.G., Tizard E.J., Dillon M.J., Weber J.N., Weiss R.A., Schulz T.F.",01406736,"Lancet",338, 8776,7,0,1,1,2,10
1991,"Relation between humoral responses to HIV gag and env proteins at seroconversion and clinical outcome of HIV infection","Cheingsong-Popov R., Panagiotidi C., Bowcock S., Aronstam A., Wadsworth J., Weber J.",09598146,"British Medical Journal",302, 6767,22,1,1,2,1,25
1990,"HIV and AIDS","Pinching A.J., Jeffries D.J., Harris J.R.W., Swirsky D., Weber J.N.",00280836,"Nature",347, 6291,0,0,0,0,0,0
1990,"Blocks on the viral exit","Weber J.",00280836,"Nature",345, 6276,1,0,0,0,0,1
1990,"Sporadic HTLV-I associated adult T-cell leukaemia (ATL) in the U.K.","Wyld P.J., Tosswill J.H.C., Mortimer P.P., Weber J.N.",00071048,"British Journal of Haematology",76, 1,3,0,0,0,0,3
1990,"Antibodies to HIV-1 nef(p27): Prevalence, significance, and relationship to seroconversion","Cheingsong-Popov R., Panagiotidi C., Ali M., Bowcock S., Watkins P., Aronstam A., Wassef M., Weber J.",08892229,"AIDS Research and Human Retroviruses",6, 9,13,0,1,1,1,15
1990,"HTLV-I infection in Britain","Weber J.",09598146,"British Medical Journal",301, 6743,4,0,0,0,0,4
1990,"Infection with human T cell leukaemia/lymphoma virus type I in patients attending an antenatal clinic in London","Tosswill J.H.C., Ades A.E., Peckham C., Mortimer P.P., Weber J.N.",09598146,"British Medical Journal",301, 6743,9,0,0,0,0,9
1990,"Antibodies to a putative HIV gp41 immunosuppressive peptide, pHIVIS (583-599), do not correlate significantly with outcome in HIV infection","Cheingsong-Popov R., Panagiotidi C., Caun K., Klasse P.J., Pipkorn R., Blomberg J., Weber J.",02699370,"AIDS",4, 3,5,0,0,0,0,5
1989,"HTLV-1 infection in Papua New Guinea: Evidence for serologic false positivity","Weber J.N., Amann S., Banatvala N., Clayden S., McAdam K.P.W.J., Palmer S., Moulsdale H., Tosswill J., Dilger P., Thorpe R.",00221899,"Journal of Infectious Diseases",159, 6,3,0,0,0,0,3
1989,"Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells","Clapham P.R., Weber J.N., Whitby D., McIntosh K., Dalgleish A.G., Maddon P.J., Deen K.C., Sweet R.W., Weiss R.A.",00280836,"Nature",337, 6205,60,2,3,5,1,66
1989,"Infection of brain cells by diverse human immunodeficiency virus isolates: Role of CD4 as receptor","Weber J., Clapham P., McKeating J., Stratton M., Robey E., Weiss R.",00221317,"Journal of General Virology",70, 10,10,0,0,0,0,10
1988,"HTLV-1 infection in tropical spastic paraparesis: lymphocyte culture and serologic response","Dalgleish A., Catovsky D., Rudge P., Richardson J., Matutes E., Cruickshank K., Newell A., Sinclair A., Thorpe R., Brasher M., Weber J.",08892229,"AIDS Research and Human Retroviruses",4, 6,9,0,0,0,0,9
1988,"Human immunodeficiency viruses: Neutralization and receptors","Weiss R.A., Clapham P.R., McClure M.O., McKeating J.A., McKnight A., Dalgleish A.G., Sattentau Q.J., Weber J.N.",08949255,"Journal of Acquired Immune Deficiency Syndromes",1, 6,6,0,0,0,0,6
1988,"HIV-2 antisera cross-neutralize HIV-1","Weiss R.A., Clapham P.R., Weber J.N., Whitby D., Tedder R.S., O'Connor T., Chamaret S., Montagnier L.",02699370,"AIDS",2, 2,17,2,1,3,4,24
1988,"Neutralizing monoclonal antibodies to the AIDS virus","Thomas E.K., Weber J.N., McClure J., Clapham P.R., Singhal M.C., Shriver M.K., Weiss R.A.",02699370,"AIDS",2, 1,18,0,0,0,0,18
1987,"Neutralization and receptor recognition of human T-lymphotropic retroviruses.","Weiss R.A., Clapham P.R., Dalgleish A.G., Weber J.N.",04400607,"Hamatologie und Bluttransfusion",31, ,0,0,0,0,0,0
1987,"Decline of anti-p24 antibody precedes antigenaemia as correlate of prognosis in HIV-1 infection","Forster S.M., Osborne L.M., Cheingsong-Popov R., Kenny C., Burnell R., Jeffries D.J., Pinching A.J., Harris J.R.W., Weber J.N.",02699370,"AIDS",1, 4,14,1,2,3,1,18
1987,"Human immunodeficiency virus infection in two cohorts of homosexual men: Neutralising sera and association of anti-GAG antibody with prognosis","Weber J.N., Weiss R.A., Roberts C.",01406736,"Lancet",1, 8525,29,1,1,2,1,32
1986,"Variable and conserved neutralization antigens of human immunodeficiency virus","Weiss R.A., Clapham P.R., Weber J.N.",00280836,"Nature",324, 6097,37,1,0,1,0,38
1986,"Three-year prospective study of HTLV-III/LAV infection in homosexual men","Weber J.N., Rogers L.A., Scott K.",01406736,"Lancet",1, 8491,3,2,1,3,0,6
1986,"Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS","Weber J.N., McCreaner A., Berrie E.",02664348,"Genitourinary Medicine",62, 3,2,0,0,0,1,3
1985,"Longitudinal immunological studies on a cohort of initially symptom-free homosexual men in London with respect to HTLV-III serology.","Pinching A.J., Weber J.N., Rogers L.A., Berrie E.L., Jeffries D.J., Harris J.R.",00652598,"Advances in Experimental Medicine and Biology",187, ,0,0,0,0,0,0
1984,"A longitudinal study of cellular immunity in male homosexuals in London","Pinching A.J., Weber J., Rogers L.A.",00778923,"Annals of the New York Academy of Sciences",437, ,0,0,0,0,0,0
1984,"Persistent generalised lymphadenopathy and acyclovir","Weber J., Jeffries D., Goudsmit J.",01406736,"Lancet",1, 8388,0,0,0,0,0,0
